Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearson, A. S.
Right arrow Articles by Fahey, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearson, A. S.
Right arrow Articles by Fahey, T. J., 3rd

Annals of Surgical Oncology, Vol 5, Issue 2 186-193, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Detection of telomerase activity in breast masses by fine-needle aspiration

A. S. Pearson, L. S. Gollahon, N. C. O'Neal, H. Saboorian, J. W. Shay and T. J. Fahey 3rd
Department of Surgery, The University of Texas Southwestern Medical Center, Dallas, USA.

BACKGROUND: Telomerase is an RNA-dependent DNA polymerase that compensates for the telomere shortening that occurs in its absence. Reactivation of telomerase is thought to be an important step in cellular immortalization, and recent studies have indicated that telomerase activity is often detected in primary human malignancies. The clinical implications of telomerase activity in human tumors are currently under investigation. METHODS: Eighty-nine samples (46 FNAs and 43 gross tissue biopsies) from 44 patients with breast masses were analyzed prospectively for the presence of telomerase activity by a modification of the telomere repeat amplification protocol (TRAP). All samples were obtained directly from the excised mass at the time of specimen removal in the operating room. RESULTS: Telomerase activity was detected in 17 of 19 (90%) FNA samples and 15 of 18 (83%) invasive breast cancer tissue biopsies. Telomerase was also detected in 9 of 16 (56%) FNAs and 8 of 15 (53%) tissue biopsies from 16 fibroadenomas. Other benign proliferative lesions (n = 5) did not have detectable telomerase activity in either FNA or tissue specimens. FNA-TRAP results correlated with the gross tissue specimen TRAP results in 95% of all cases. CONCLUSION: The FNA-TRAP assay for telomerase detection is a highly sensitive and accurate method for the detection of telomerase activity in breast masses. Future application of these techniques should facilitate evaluation of telomerase as a tumor marker in the clinical management of breast and other solid malignancies.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
T. Matsuo, E. Hiyama, T. Sugita, S. Shimose, T. Kubo, Y. Mochizuki, N. Adachi, K. Kojima, P. Sharman, and M. Ochi
Telomerase Activity in Giant Cell Tumors of Bone
Ann. Surg. Oncol., October 1, 2007; 14(10): 2896 - 2902.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Poremba, K. R. Shroyer, M. Frost, R. Diallo, F. Fogt, K.-L. Schafer, H. Burger, A. L. Shroyer, B. Dockhorn-Dworniczak, and W. Boecker
Telomerase Is a Highly Sensitive and Specific Molecular Marker in Fine-Needle Aspirates of Breast Lesions
J. Clin. Oncol., July 1, 1999; 17(7): 2020 - 2020.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society of Surgical Oncology.